Français
ItalianoBond Gilead Sciences 4.9% ( US375558CM38 ) in USD
| Issuer | Gilead Sciences | ||||||
| Market price |  100.00 % ⇌ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US375558CM38 ( in USD )
|
||||||
| Interest rate | 4.9% per year ( payment 2 times a year) | ||||||
| Maturity | 20/05/2034 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 500 000 000 USD | ||||||
| Cusip | 375558CM3 | ||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 20/11/2026 ( In 86 days ) | ||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CM38, pays a coupon of 4.9% per year. The coupons are paid 2 times per year and the Bond maturity is 20/05/2034 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CM38, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CM38, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||